Low-grade imported raw materials should be discouraged

Some pharmaceutical manufacturers have been shown to import pharmaceutical bulks in low-grade purity, triggering some common types of unfair practices such as price fixing, illicit inducement of customers in the process of delivery and the abuse of patent rights to dominate the market.

Experts said that efforts for self-purification in the local pharmaceutical bulk sector are needed to root ...